TABLE 2.
Estimate type for test | Genital tract
|
Peripheral blood
|
||||
---|---|---|---|---|---|---|
No. positive | Median | Range | No. positive | Median | Range | |
Kit based | ||||||
Roche | 77 | 3.24 | 2.61–5.27 | 250 | 3.61 | 2.60–6.05 |
OTC | 80 | 3.31 | 1.95–5.90 | 222 | 3.87 | 2.66–6.56 |
NASBA-QT | 48 | 3.36 | 2.18–5.90 | 122 | 3.90 | 2.74–5.98 |
NucliSens | 32 | 3.27 | 1.95–4.65 | 100 | 3.84 | 2.66–6.56 |
VQA based | ||||||
Roche | 77 | 2.97 | 1.66–5.36 | 250 | 3.61 | 2.21–6.20 |
OTC | 80 | 3.26 | 0.60–5.13 | 222 | 3.88 | 1.18–6.59 |
NASBA-QT | 48 | 3.24 | 0.60–5.13 | 122 | 3.93 | 1.18–6.29 |
NucliSens | 32 | 3.38 | 1.79–4.85 | 100 | 3.81 | 1.92–6.59 |